The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.

ABSTRACT:

SUBMITTER: Badawy SM 

PROVIDER: S-EPMC9303221 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature